Christine N Manser
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Vavricka S, Misselwitz B, Scharl M, Heinrich H, Manser C, Safroneeva E, Raja Ali R, Rogler G, Schoepfer A, Greuter T, Zeitz J, Biedermann L, Juillerat P, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, Protic M, Michetti P, Straumann A, Fournier N. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Inflamm Bowel Dis 2017
Apr 27, 2017Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study
Apr 27, 2017Inflamm Bowel Dis 2017
Vavricka Stephan R, Misselwitz Benjamin, Scharl Michael, Heinrich Henriette, Manser Christine N, Safroneeva Ekaterina, Raja Ali Raja Affendi, Rogler Gerhard, Schoepfer Alain M, Greuter Thomas, Zeitz Jonas, Biedermann Luc, Juillerat Pascal, Gubler Martin, Gantenbein Claudine, Spoerri Muriel, Froehlich Florian, Seibold Frank, Protic Marijana, Michetti Pierre, Straumann Alex, Fournier Nicolas
Meta-Analysis of the Effect of Bowel Preparation on Adenoma Detection: Early Adenomas Affected Stronger than Advanced Adenomas
Sulz M, Kröger A, Prakash M, Manser C, Heinrich H, Misselwitz B. Meta-Analysis of the Effect of Bowel Preparation on Adenoma Detection: Early Adenomas Affected Stronger than Advanced Adenomas. PloS one 2016; 11:e0154149.
Jun 3, 2016Meta-Analysis of the Effect of Bowel Preparation on Adenoma Detection: Early Adenomas Affected Stronger than Advanced Adenomas
Jun 3, 2016PloS one 2016; 11:e0154149
Sulz Michael, Kröger Arne, Prakash Meher, Manser Christine N, Heinrich Henriette, Misselwitz Benjamin
Risk factors for complications in patients with ulcerative colitis
Manser C, Borovicka J, Seibold F, Vavricka S, Lakatos P, Fried M, Rogler G. Risk factors for complications in patients with ulcerative colitis. United European Gastroenterol J 2016; 4:281-7.
Jan 19, 2016Risk factors for complications in patients with ulcerative colitis
Jan 19, 2016United European Gastroenterol J 2016; 4:281-7
Manser Christine N, Borovicka Jan, Seibold Frank, Vavricka Stephan R, Lakatos Peter L, Fried Michael, Rogler Gerhard
Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection
Rau M, Geier A, Mullhaupt B, Semela D, Moradpour D, Dufour J, Dill M, Schmitt J, Weisskopf M, Becker P, Manser C, Russmann S, Stickel F, Swiss Hepatitis C Cohort Study Group (SCCS). Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. J Hepatol 2012; 58:669-75.
Nov 27, 2012Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection
Nov 27, 2012J Hepatol 2012; 58:669-75
Rau Monika, Geier Andreas, Mullhaupt Beat, Semela David, Moradpour Darius, Dufour Jean-François, Dill Michael T, Schmitt Johannes, Weisskopf Michael, Becker Philip P, Manser Christine N, Russmann Stefan, Stickel Felix, Swiss Hepatitis C Cohort Study Group (SCCS)